Optimum Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $467K | Sell |
3,236
-109
| -3% | -$14.9K | 0.19% | 106 |
|
|
2025
Q2 | $423K | Buy |
3,345
+84
| +3% | +$10.3K | 0.18% | 106 |
|
|
2025
Q1 | $417K | Buy |
3,261
+19
| +0.6% | +$2.58K | 0.2% | 105 |
|
|
2024
Q4 | $429K | Buy |
3,242
+56
| +2% | +$7.87K | 0.19% | 111 |
|
|
2024
Q3 | $464K | Buy |
3,186
+162
| +5% | +$23.4K | 0.2% | 106 |
|
|
2024
Q2 | $415K | Buy |
3,024
+85
| +3% | +$11.3K | 0.19% | 114 |
|
|
2024
Q1 | $403K | Sell |
2,939
-129
| -4% | -$17.6K | 0.19% | 113 |
|
|
2023
Q4 | $417K | Sell |
3,068
-370
| -11% | -$45.1K | 0.21% | 105 |
|
|
2023
Q3 | $420K | Buy |
3,438
+44
| +1% | +$5.59K | 0.22% | 111 |
|
|
2023
Q2 | $431K | Sell |
3,394
-62
| -2% | -$8.05K | 0.21% | 114 |
|
|
2023
Q1 | $446K | Buy |
3,456
+94
| +3% | +$12.3K | 0.23% | 106 |
|
|
2022
Q4 | $441K | Sell |
3,362
-516
| -13% | -$66.7K | 0.24% | 102 |
|
|
2022
Q3 | $454K | Sell |
3,878
-251
| -6% | -$31.2K | 0.24% | 96 |
|
|
2022
Q2 | $486K | Buy |
4,129
+127
| +3% | +$15.1K | 0.24% | 97 |
|
|
2022
Q1 | $521K | Buy |
4,002
+17
| +0.4% | +$2.21K | 0.22% | 105 |
|
|
2021
Q4 | $608K | Buy |
3,985
+30
| +0.8% | +$4.64K | 0.24% | 94 |
|
|
2021
Q3 | $639K | Sell |
3,955
-339
| -8% | -$57K | 0.27% | 88 |
|
|
2021
Q2 | $703K | Sell |
4,294
-244
| -5% | -$37.6K | 0.22% | 99 |
|
|
2021
Q1 | $683K | Buy |
4,538
+247
| +6% | +$39.2K | 0.2% | 111 |
|
|
2020
Q4 | $650K | Buy |
4,291
+73
| +2% | +$10.4K | 0.2% | 112 |
|
|
2020
Q3 | $571K | Buy |
4,218
+39
| +0.9% | +$5.29K | 0.19% | 117 |
|
|
2020
Q2 | $571K | Buy |
4,179
+122
| +3% | +$15.6K | 0.2% | 117 |
|
|
2020
Q1 | $437K | Buy |
4,057
+203
| +5% | +$23.4K | 0.18% | 135 |
|
|
2019
Q4 | $464K | Sell |
3,854
-10
| -0.3% | -$1.12K | 0.14% | 169 |
|
|
2019
Q3 | $384K | Buy |
3,864
+70
| +2% | +$7.33K | 0.12% | 180 |
|
|
2019
Q2 | $414K | Buy |
3,794
+184
| +5% | +$19.6K | 0.13% | 165 |
|
|
2019
Q1 | $404K | Buy |
3,610
+79
| +2% | +$8.66K | 0.13% | 170 |
|
|
2018
Q4 | $340K | Buy |
3,531
+63
| +2% | +$6.69K | 0.12% | 177 |
|
|
2018
Q3 | $423K | Buy |
3,468
+194
| +6% | +$22.8K | 0.12% | 176 |
|
|
2018
Q2 | $360K | Sell |
3,274
-227
| -6% | -$24.3K | 0.1% | 201 |
|
|
2018
Q1 | $374K | Buy |
3,501
+104
| +3% | +$11.5K | 0.11% | 191 |
|
|
2017
Q4 | $363K | Buy |
+3,397
| New | +$363K | 0.12% | 199 |
|
|
2015
Q1 | $24K | Hold |
210
| – | – | 0.01% | 650 |
|
|
2014
Q4 | $21K | Buy |
+210
| New | +$20.4K | 0.01% | 698 |
|
Other funds holding IBB
CB
Optimum Investment Advisors's IBB Position: Q3 2025 in Review
Optimum Investment Advisors reduced its iShares Biotechnology ETF (IBB) stake by 3.3% in Q3 2025, selling an estimated $14.9K and leaving 3,236 shares worth $467K. The position accounts for 0.19% of the portfolio, ranked #106.
Optimum Investment Advisors first reported a position in IBB in Q4 2014 and has held it in 34 quarters since. The position peaked at $703K in Q2 2021. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.
- Optimum Investment Advisors held 3,236 shares of iShares Biotechnology ETF worth $467K as of Q3 2025.
- Optimum Investment Advisors sold 109 iShares Biotechnology ETF shares in Q3 2025, an estimated $14.9K.
- iShares Biotechnology ETF made up 0.19% of Optimum Investment Advisors's portfolio in Q3 2025, its #106 holding.
- Optimum Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 34 quarters since.
- Optimum Investment Advisors's iShares Biotechnology ETF position peaked at $703K in Q2 2021.
- 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.
Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.